## BBY: Best Buy Co., Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -4.5% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($68.25)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Bed Bath & Beyond & Brand House Collective Announce Chief of Stores**
- Source: Home Furnishings Business | 20251208T010912 | Somewhat-Bullish | Relevance: 99%
-  Bed Bath & Beyond, Inc. and The Brand House Collective, Inc. have appointed Glen Cary as Chief of Stores for Bed Bath & Beyond and its associated brands. Cary brings over 25 years of retail leadership experience, including previous roles at Bed Bath & Beyond and buybuy BABY, to drive retail sales, strengthen operational discipline, and modernize the store fleet. The leadership team expects Cary to deliver exceptional in-store experiences and significant growth for the brands.

**2. 1832 Asset Management L.P. Buys Shares of 21,371 Best Buy Co., Inc. $BBY**
- Source: MarketBeat | 20251207T080720 | Somewhat-Bullish | Relevance: 99%
-  1832 Asset Management L.P. initiated a new position in Best Buy Co., Inc. (NYSE:BBY) by purchasing 21,371 shares valued at approximately $1.435 million in the second quarter. Other institutional investors also adjusted their stakes in BBY, with 80.96% of the stock owned by hedge funds and institutions. Best Buy recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $0.95 per share.

**3. Amundi Increases Stake in Best Buy Co., Inc. $BBY**
- Source: MarketBeat | 20251207T110756 | Neutral | Relevance: 99%
-  Amundi has increased its stake in Best Buy Co., Inc. by 1.3%, bringing its total holdings to 2,813,882 shares valued at approximately $203.4 million. This move comes amidst significant insider selling, particularly by Chairman Richard M. Schulze, and Best Buy's recent positive earnings report and an announced quarterly dividend of $0.95 per share.

**4. Brown Advisory Inc. Lowers Stake in Best Buy Co., Inc. $BBY**
- Source: MarketBeat | 20251208T090816 | Neutral | Relevance: 99%
-  Brown Advisory Inc. reduced its stake in Best Buy Co., Inc. (NYSE:BBY) by 25.6% during the second quarter, selling 71,251 shares and now owning 206,813 shares valued at approximately $13.88 million. Despite this, Best Buy exceeded Q2 earnings expectations with $1.40 EPS and $9.67 billion revenue, and analysts currently rate the stock as "Hold" with an average price target of $84.74. The company also announced a quarterly dividend of $0.95, resulting in a 5.1% yield, and insiders have sold a significant amount of shares in the past three months.

**5. Best Buy Co., Inc. $BBY Position Lessened by Marshall Wace LLP**
- Source: MarketBeat | 20251208T113958 | Neutral | Relevance: 98%
-  Marshall Wace LLP significantly reduced its stake in Best Buy Co., Inc. (NYSE:BBY) by 68.8% in Q2, selling over 1.1 million shares. Despite this, other hedge funds increased their positions, and 80.96% of the stock is held by institutional investors. Best Buy recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 7, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $80 | $85 | -6% |
| 2025-11-26 | Truist Securiti | $84 | $79 | +6% |
| 2025-11-26 | Barclays | $81 | $74 | +9% |
| 2025-11-26 | UBS | $96 | $93 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-26 | Truist Securiti | main | Hold |
| 2025-11-26 | Barclays | main | Equal-Weight |
| 2025-11-26 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 8 ($109.58M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 11.8% (-0.5%)
- Vanguard Group Inc: 11.4% (+2.4%)
- State Street Corpora: 6.3% (-2.2%)
- JPMORGAN CHASE & CO: 4.5% (+74.1%)
- Charles Schwab Inves: 3.5% (+3.6%)

### Key Risks

1. Heavy insider selling: $110M sold (8 transactions in 90 days).
2. Near-term weakness: 6.0% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 7 raises (avg +7%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.99 indicates undervaluation relative to growth. Quality metrics strong (ROE 22%). Analyst sentiment positive (7 raises, avg +7%). Insider selling cluster ($109.6M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.5B |
| Beta | 1.39 |
| 52W Range | $54.99 - $91.68 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.99 |
| Forward P/E | 10.8 |
| Current P/E | 11.5 |
| YoY Growth | 6.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.5% over 5 days). Below STRENGTH zone by 7.5pp (needs >3.0% for momentum thesis). Underperforming sector by 3.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.00x) but short-term weakness (below SMA20).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.54% (CS: 9) | Weak |
| RSI_14 | 39.4 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 0.965x | Below |
| vs SMA50 | 0.940x | Below |
| vs SMA200 | 1.005x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $73.17
- **Stop Loss:** $68.25 (6.7% risk)
- **Target:** $78.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 101
- **Position Value:** $7,390.17
- **Portfolio %:** 7.39%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-03-03 (Est: $2.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.31 | $1.40 | +6.7% |
| 2025Q3 | $1.22 | $1.28 | +4.5% |
| 2025Q2 | $1.10 | $1.15 | +5.0% |
| 2025Q1 | $2.41 | $2.58 | +7.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*